Someone with a lot of money to spend has taken a bullish stance on Amgen AMGN.
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with AMGN, it often means somebody knows something is about to happen.
So how do we know what this whale just did?
Today, Benzinga's options scanner spotted 36 uncommon options trades for Amgen.
This isn't normal.
The overall sentiment of these big-money traders is split between 58% bullish and 41%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $93,428, and 34 are calls, for a total amount of $2,451,616.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $115.0 to $260.0 for Amgen over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Amgen's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amgen's whale trades within a strike price range from $115.0 to $260.0 in the last 30 days.
Amgen Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| AMGN | CALL | SWEEP | BULLISH | 01/19/24 | $215.00 | $174.3K | 60 | 115 |
| AMGN | CALL | SWEEP | BULLISH | 01/19/24 | $215.00 | $164.0K | 60 | 69 |
| AMGN | CALL | SWEEP | BULLISH | 01/19/24 | $215.00 | $159.0K | 60 | 249 |
| AMGN | CALL | SWEEP | BULLISH | 01/19/24 | $215.00 | $124.3K | 60 | 159 |
| AMGN | CALL | SWEEP | NEUTRAL | 01/19/24 | $215.00 | $123.9K | 60 | 335 |
Where Is Amgen Standing Right Now?
- With a volume of 1,118,988, the price of AMGN is down -0.14% at $260.44.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 85 days.
What The Experts Say On Amgen:
- RBC Capital has decided to maintain their Sector Perform rating on Amgen, which currently sits at a price target of $253.
- Credit Suisse has decided to maintain their Outperform rating on Amgen, which currently sits at a price target of $200.
- Barclays has decided to maintain their Underweight rating on Amgen, which currently sits at a price target of $210.
- Oppenheimer downgraded its action to Outperform with a price target of $280
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Amgen, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
